FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1074681000202102: Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
11777891000202114 Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
11793721000202119 Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5981831000052116 dolutegravir (som dolutegravirnatrium) 50 mg och lamivudin 300 mg, oral tablett sv Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Plays role Antiretroviral therapeutic role true Inferred relationship Some
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Lamivudine (substance) true Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Lamivudine (substance) true Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Dolutegravir sodium true Inferred relationship Some 2
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Dolutegravir true Inferred relationship Some 2
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start